Aura Biosciences Inc (AURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | ||
| Net Income | -22,206 | -17,299 |
| Depreciation Amortization | 831 | 605 |
| Accounts payable and accrued liabilities | N/A | -1,837 |
| Other Working Capital | -3,679 | -4,427 |
| Other Operating Activity | 733 | 2,394 |
| Operating Cash Flow | $-24,321 | $-20,564 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -771 | -639 |
| Investing Cash Flow | $-771 | $-639 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | N/A | 148 |
| Other Financing Activity | 10,036 | 4,755 |
| Financing Cash Flow | $10,036 | $4,903 |
| Beginning Cash Position | 32,543 | 32,543 |
| End Cash Position | 17,487 | 16,243 |
| Net Cash Flow | $-15,056 | $-16,300 |
| Free Cash Flow | ||
| Operating Cash Flow | -24,321 | -20,564 |
| Capital Expenditure | N/A | -639 |
| Free Cash Flow | -24,321 | -21,203 |